Atossa Therapeutics, Inc. (ATOS) NASDAQ
5.37
+0.255(+4.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.37
+0.255(+4.99%)
Currency In USD
| Market Cap | 76.21M |
| Enterprise Value | 34.91M |
| P/E Ratio | -1.33 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.17 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.73 |
| Return On Equity | -0.66 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16,000 |
| EBITDA | -37.13M |
| Net Income | -34.77M |
| Diluted EPS | -4.04 |
| Total Cash | 41.3M |
| Total Cash/Share | 4.8 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.53 |
| Book Value Per Share | 4.57 |
| 52-Week Change | -44.35 |
| 52-Week High | 19.35 |
| 52-Week Low | 3.76 |
| Moving Average 50 Days | 5.56 |
| Moving Average 200 Days | 10.58 |
| Average Volume | 140,129 |
| Shares Outstanding | 8.61M |
| % Held by Institutions | 16.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 02, 2026 |